Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,853 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 28,986 · Balance 66,853 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 28,986 · Balance 0 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,441 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 30,441 · Balance 30,441 F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026.
F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 30,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001804442-26-000002 · wk-form4_1779397989.xml · derivative · entry 3 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,441 Underlying: Common Stock · 30,441 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Read SEC document |
| May 20, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 28,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001804442-26-000002 · wk-form4_1779397989.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. F2 · derivative.expiration_date: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. Read SEC document |
| May 20, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 28,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001804442-26-000002 · wk-form4_1779397989.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 28,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000068 · wk-form4_1748030786.xml · derivative · entry 3 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,986 Underlying: Common Stock · 28,986 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 17,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000068 · wk-form4_1748030786.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025. F2 · derivative.expiration_date: On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 17,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000068 · wk-form4_1748030786.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 17,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000123 · wk-form4_1716582331.xml · derivative · entry 3 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,467 Underlying: Common Stock · 17,467 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000123 · wk-form4_1716582331.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024. F3 · derivative.expiration_date: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000123 · wk-form4_1716582331.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008846 · form4-05262023_080518.xml · derivative · entry 3 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,834 Underlying: Common Stock · 9,834 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008846 · form4-05262023_080518.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,726 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 26, 2022, the reporting person was granted 6,726 restricted stock units, vesting in full on May 24, 2023. F3 · derivative.expiration_date: On May 26, 2022, the reporting person was granted 6,726 restricted stock units, vesting in full on May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,726 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-008846 · form4-05262023_080518.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 734 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003169 · form4-02232023_090217.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 734 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments. F3 · derivative.expiration_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-003169 · form4-02232023_090217.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005899 · form4-05312022_010507.xml · derivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726 Underlying: Common Stock · 6,726 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005231 · form4-05182022_010525.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. F3 · derivative.expiration_date: On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-005231 · form4-05182022_010525.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 734 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001490 · edgar.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734 Underlying: Common Stock · 734 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments. F3 · derivative.expiration_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-001490 · edgar.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005482 · edgar.xml · derivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:44 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 734 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002023 · edgar.xml · derivative · entry 2 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468 Underlying: Common Stock · 734 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three equal annual installments. F3 · derivative.expiration_date: On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three equal annual installments. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:44 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002023 · edgar.xml · nonDerivative · entry 1 Jacobson Catherine · CIK 0001804442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.